Innovation
18 patent families (7 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady. Cited 1,065 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 8 |
| 2022 | 9 |
| 2023 | 12 |
| 2024 | 11 |
| 2025 | 12 |
| 2026 | 3 |
Social engagement
Social engagement: 2.7K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
7 investors on record; lead investors include Harel Group, Israel Biotech Fund, Deep Insight.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 29% |
| Private equity | 2 | 29% |
| Other / undisclosed | 3 | 43% |
Recent activity
22 Jun 2026
Milestone
regulatory
26 Apr 2026
Milestone
Biond Biologics
2 Sep 2025
Event
23rd Annual Global Healthcare Conference